Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

J.M. Meerum Terwogt; G. Groenewegen; D. Pluim; M. Maliepaard; M.M. Tibben; A. Huisman; W.W. ten Bokkel Huinink; M. Schot; H. Welbanh; E.E. Voest; J.H. Beijnen; J.H.M. Schellens

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

Translated title of the contribution: Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

J.M. Meerum Terwogt, G. Groenewegen, D. Pluim, M. Maliepaard, M.M. Tibben, A. Huisman, W.W. ten Bokkel Huinink, M. Schot, H. Welbanh, E.E. Voest, J.H. Beijnen, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
Original language	Undefined/Unknown
Pages (from-to)	201-210
Number of pages	9
Journal	Cancer Chemotherapy and Pharmacology
Volume	49
Publication status	Published - 2002

Cite this

@article{dd6aac94d5ae4af5af025185cf1df955,

title = "Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin",

author = "{Meerum Terwogt}, J.M. and G. Groenewegen and D. Pluim and M. Maliepaard and M.M. Tibben and A. Huisman and {ten Bokkel Huinink}, W.W. and M. Schot and H. Welbanh and E.E. Voest and J.H. Beijnen and J.H.M. Schellens",

year = "2002",

language = "Undefined/Unknown",

volume = "49",

pages = "201--210",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer-Verlag",

}

TY - JOUR

T1 - Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

AU - Meerum Terwogt, J.M.

AU - Groenewegen, G.

AU - Pluim, D.

AU - Maliepaard, M.

AU - Tibben, M.M.

AU - Huisman, A.

AU - ten Bokkel Huinink, W.W.

AU - Schot, M.

AU - Welbanh, H.

AU - Voest, E.E.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0344-5704

VL - 49

SP - 201

EP - 210

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

ER -